SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-079029
Filing Date
2014-11-10
Accepted
2014-11-10 17:00:39
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a14-19568_110q.htm 10-Q 721420
2 EX-31.1 a14-19568_1ex31d1.htm EX-31.1 10998
3 EX-31.2 a14-19568_1ex31d2.htm EX-31.2 11567
4 EX-32.1 a14-19568_1ex32d1.htm EX-32.1 6716
5 EX-32.2 a14-19568_1ex32d2.htm EX-32.2 7306
  Complete submission text file 0001104659-14-079029.txt   2347154

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gtxi-20140930.xml EX-101.INS 210430
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gtxi-20140930.xsd EX-101.SCH 15592
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gtxi-20140930_cal.xml EX-101.CAL 20847
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gtxi-20140930_def.xml EX-101.DEF 37808
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT gtxi-20140930_lab.xml EX-101.LAB 179761
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gtxi-20140930_pre.xml EX-101.PRE 116164
Mailing Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103
Business Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103 901-523-9700
GTX INC /DE/ (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50549 | Film No.: 141209503
SIC: 2834 Pharmaceutical Preparations